Shots:
- QIAGEN has entered into a definitive agreement to acquire Genoox, a provider of AI-driven software that allows clinical laboratories to scale & accelerate the analysis of complex genetic tests
- As per the deal, Genoox will receive $70M in cash & up to $10M in additional milestone payments
- Acquisition adds Franklin, Genoox’s cloud-based platform, to QIAGEN’s Digital Insights portfolio, with plans to integrate QIAGEN’s genomic content, incl. Human Gene Mutation Database (HGMD), Catalogue of Somatic Mutations in Cancer (COSMIC), & QIAGEN Knowledge Base to improve Franklin’s diagnostic capabilities & lab efficiency
Ref: Businesswire | Image: Genoox
Related News:- Novartis to Acquire Regulus Therapeutics for ~$1.7B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click Here for Full Press Release
